Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates:
(R)-[11C]NR2B-Me
(R)-[18F]OF-Me-NB1
(S)-[18F]OF-NB1
GluN2B subunit
NMDA receptor
Positron emission tomography
glutamate
Journal
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
pubmed:
26
2
2022
medline:
9
7
2022
entrez:
25
2
2022
Statut:
ppublish
Résumé
The NMDA receptor GluN2B subunit is a target of interest in neuropsychiatric disorders but to date there is no selective radiotracer available to quantify its availability
Identifiants
pubmed: 35209743
doi: 10.1177/0271678X221084416
pmc: PMC9274863
doi:
Substances chimiques
Radiopharmaceuticals
0
Receptors, N-Methyl-D-Aspartate
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1398-1409Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIH HHS
ID : S10 OD018034
Pays : United States
Organisme : NIH HHS
ID : S10 OD019967
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH107803
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 MH002795
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 MH002793
Pays : United States
Références
Eur J Med Chem. 2020 Aug 15;200:112447
pubmed: 32450321
J Nucl Med. 2020 Aug;61(8):1212-1220
pubmed: 31924728
J Gen Physiol. 2018 Aug 6;150(8):1081-1105
pubmed: 30037851
J Med Chem. 2012 Oct 11;55(19):8272-8282
pubmed: 22853801
J Cereb Blood Flow Metab. 2020 Sep;40(9):1769-1777
pubmed: 32663096
Magn Reson Imaging. 2017 Nov;43:144-150
pubmed: 28755862
Pharmacol Rev. 2018 Jul;70(3):621-660
pubmed: 29945898
Neurochem Int. 2012 Jan;60(2):170-6
pubmed: 22197911
J Cereb Blood Flow Metab. 2014 Jul;34(7):1162-8
pubmed: 24736889
Mol Cell Neurosci. 2011 Dec;48(4):308-20
pubmed: 21600287
J Nucl Med. 2021 Feb;62(2):259-265
pubmed: 32737247
J Med Chem. 1999 Jul 29;42(15):2993-3000
pubmed: 10425109
Molecules. 2020 Oct 16;25(20):
pubmed: 33081223
J Nucl Med. 2022 Jun;63(6):936-941
pubmed: 34620732
Nat Rev Neurosci. 2013 Jun;14(6):383-400
pubmed: 23686171
Philos Trans R Soc Lond B Biol Sci. 2013 Dec 02;369(1633):20130163
pubmed: 24298164
Arch Gen Psychiatry. 2006 Aug;63(8):856-64
pubmed: 16894061
Expert Opin Ther Pat. 2020 Oct;30(10):743-767
pubmed: 32926646
Neuron. 2019 Mar 6;101(5):774-778
pubmed: 30844397
Appl Radiat Isot. 2001 Feb;54(2):203-8
pubmed: 11200881
J Nucl Med. 2018 Apr;59(4):698-703
pubmed: 29191857
J Cereb Blood Flow Metab. 2010 Jan;30(1):46-50
pubmed: 19738632
J Med Chem. 2019 Nov 14;62(21):9450-9470
pubmed: 31657559
J Cereb Blood Flow Metab. 2002 Oct;22(10):1271-81
pubmed: 12368666
Acta Pharmacol Sin. 2021 Mar;42(3):491-498
pubmed: 32661351
Mol Pharmacol. 2012 Aug;82(2):344-59
pubmed: 22596351
J Nucl Med. 2019 Aug;60(8):1167-1173
pubmed: 30683765
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Neuron. 1994 Mar;12(3):529-40
pubmed: 7512349
Science. 2002 Oct 25;298(5594):846-50
pubmed: 12399596
J Nucl Med. 2018 Jul 20;:
pubmed: 30030340
Neuroreport. 1992 Dec;3(12):1138-40
pubmed: 1493227
Nature. 1999 Sep 2;401(6748):63-9
pubmed: 10485705
Nucl Med Biol. 2000 Oct;27(7):657-60
pubmed: 11091108
Mol Neurobiol. 2021 Jul;58(7):3443-3456
pubmed: 33723767
J Neurosci. 2014 Aug 20;34(34):11325-38
pubmed: 25143613
Arch Gen Psychiatry. 1994 Mar;51(3):199-214
pubmed: 8122957
J Neurosci. 2002 May 1;22(9):3628-37
pubmed: 11978838
Biol Psychiatry. 2012 Aug 15;72(4):331-8
pubmed: 22516044
Neuropharmacology. 2014 Nov;86:174-80
pubmed: 25063581
Nucl Med Biol. 2000 Aug;27(6):627-30
pubmed: 11056380